AP. Alltracel PH.

    


Loeb Partners Corporation



Appendix 3 Disclosure Forms                                         Ap 9


Page 1 of 4 FORM 8.1/8.3 IRISH TAKEOVER PANEL

Date of disclosure......March 14, 2008

Lodge with the Stock Exchange (which may publicise) and with the Panel. Use
separate form for each class of securities in which dealings have been made.

DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(i) and 8.3 OF THE IRISH TAKEOVER PANEL ACT,
                           1997, TAKEOVER RULES, 2007

Date of Dealing ............................March 13, 2007

Dealing in (name of company)......Alltracel Pharmaceuticals Plc

(1) Class of securities (e.g. ordinary shares) ordinary shares (via Swap)

(2) Amount bought 100,000

Amount sold

Price per unit 12 7/8 GBp

(4) Party making disclosure...Loeb Holding Corporation........

(3) Resultant total of the same class owned or controlled (and percentage of
class) 1,500,000........................................1.16% (%)

(5) EITHER (a) Name of purchaser/vendor (Note 1) OR (b) If dealing for
discretionary client(s), name of fund management organisation

Loeb Holding Corporation

(6) Reason for disclosure (Note 2)

YES/NO(a) (i) offeror or associate of offeror (Note 3)

YES/NO(ii) offeree or associate of offeree Specify which category or categories
of associate ((a) to (l) page 3/4) ..If category (l), explain ..........

(b) Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more the
class of relevant securities dealt in) YES/NO

Signed, for and on behalf of the party named in (4) above ..../Shelby
Drescher/...........

(Also print name of signatory)........Shelby Drescher....

Telephone and extension number....212-483-7070

Alltracel Pharmaceuticals (LSE:AP.)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025

Alltracel Pharmaceuticals (LSE:AP.)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025